E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Price$63.46
Change (%) Stock is Down 0.02 (0.03%)
Intraday High$64.25
Intraday Low$63.30
Volume2,787,037
Data as of 10/31/14 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
Headlines More >
TitleDate
Quest Diagnostics Reports Third Quarter 2014 Financial Results
MADISON, N.J., Oct. 23, 2014 /PRNewswire/ -- Revenues from continuing operations of $1.9 billion, up 6.5% versus prior year Adjusted diluted EPS from continuing operations of $1.10, up 7.8% versus prior year Reported diluted EPS from continuing operations of $0.88, compared to $2.66 in 2013, which included a net gain of $1.80 per diluted share from asset sales Full year 2014 revenues now expected to grow approximately 3.5%, versus 2.5% to 3.5% previously Full year 2014 adjusted dilu... 
10/23/14
Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
MADISON, N.J., Oct. 22, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Jeffrey M. Leiden, M.D., Ph.D., to serve as a director, effective December 1, 2014. Including Dr. Leiden, the Board has 11 members. Dr. Leiden is the Chairman, President and CEO of Vertex Pharmaceuticals.   Dr. Leiden has more than 20 years of scientific and commercial experience in the pharmaceut... 
10/22/14
Quest Diagnostics To Release Third Quarter 2014 Financial Results On October 23
MADISON, N.J., Oct. 7, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2014 results on Thursday, October 23, 2014, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469. The company suggests pa... 
10/07/14
Quest Diagnostics Unveils New State-of-the-Art Clinical Laboratory in Marlborough, Massachusetts
Congresswoman Niki Tsongas, Representative Danielle Gregoire and Marlborough Mayor Arthur Vigeant join community event to open 200,000 square-foot "lab of the future" designed to deliver innovative, efficient diagnostic information services to New England Medical experts from UMass Memorial Medical Group and the University of Massachusetts to provide scientific leadership for testing onsite MARLBOROUGH, Mass., Oct. 2, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leadin... 
10/02/14
Upcoming EventsMore >
DateTitle
11/05/14
Quest Diagnostics Investor Day
Contact Us:
Dan Haemmerle
Executive Director Investor Relations
973-520-2900
Investor@QuestDiagnostics.com

Company Calendar
November 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-6-5-4-3-2-11
2345
11/05/14
9:00 a.m. ET
Quest Diagnostics Investor Day
678
9101112131415
16171819202122
23242526272829
30515253545556

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.